A multi-institutional retrospective pooled outcome analysis of molecularly annotated pediatric supratentorial ZFTA-fused ependymoma
暂无分享,去创建一个
David C. Jones | S. Pfister | D. Eisenstat | U. Schüller | K. Pajtler | H. Witt | Michael D. Taylor | T. Pietsch | R. Kortmann | S. Rutkowski | N. Gottardo | M. Warmuth-Metz | V. Ramaswamy | J. Hansford | K. von Hoff | M. Mynarek | D. Sumerauer | Dong-Anh Khuong-Quang | B. Bison | Hallie Coltin | C. White | M. Benesch | Amanda J Luck | E. Algar | K. Kinross | O. Wells | N. Gerber | D. Obrecht | M. Zápotocký | C. H. Ng
[1] G. Reifenberger,et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. , 2021, Neuro-oncology.
[2] David T. W. Jones,et al. Cross-species genomics reveals oncogenic dependencies in ZFTA/C11orf95 fusion-positive supratentorial ependymomas. , 2021, Cancer discovery.
[3] S. Ballereau,et al. ZFTA-translocations constitute ependymoma chromatin remodeling and transcription factors. , 2021, Cancer discovery.
[4] D. Parsons,et al. ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma. , 2021, Cancer discovery.
[5] R. McLendon,et al. Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q. , 2021, Neuro-oncology.
[6] F. Andreiuolo,et al. Supratentorial ependymoma in childhood: more than just RELA or YAP , 2021, Acta Neuropathologica.
[7] F. Andreiuolo,et al. CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort , 2020, Acta Neuropathologica.
[8] K. Aldape,et al. cIMPACT‐NOW update 7: advancing the molecular classification of ependymal tumors , 2020, Brain pathology.
[9] T. Merchant,et al. Molecular Grouping and Outcomes of Young Children with Newly Diagnosed Ependymoma Treated on the Multi-Institutional SJYC07 Trial. , 2019, Neuro-oncology.
[10] T. Zhou,et al. Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] M. Kool,et al. Epidemiology, molecular classification and WHO grading of ependymoma. , 2018, Journal of neurosurgical sciences.
[12] T. Merchant. Current Clinical Challenges in Childhood Ependymoma: A Focused Review. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] K. Aldape,et al. The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants , 2016, Acta Neuropathologica.
[14] F. Andreiuolo,et al. A Global View on the Availability of Methods and Information in the Neuropathological Diagnostics of CNS Tumors: Results of an International Survey Among Neuropathological Units , 2016, Brain pathology.
[15] G. Reifenberger,et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.
[16] Gary D Bader,et al. Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups. , 2015, Cancer cell.
[17] J. Finlay,et al. Outcome of infants and young children with newly diagnosed ependymoma treated on the “Head Start” III prospective clinical trial , 2013, Journal of Neuro-Oncology.
[18] I. Sardi,et al. Infant ependymoma in a 10-year AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) experience with omitted or deferred radiotherapy. , 2011, International journal of radiation oncology, biology, physics.
[19] P. Lichter,et al. Molecular staging of intracranial ependymoma in children and adults. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] T. Merchant,et al. Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. , 2009, The Lancet. Oncology.
[21] Richard G Grundy,et al. Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study. , 2007, The Lancet. Oncology.
[22] D. Frappaz,et al. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Jeffrey C. Allen,et al. Treatment of Intracranial Ependymoma by Surgery Alone , 1998, Pediatric Neurosurgery.
[24] S. Khatua,et al. Current therapy and the evolving molecular landscape of paediatric ependymoma. , 2017, European journal of cancer.
[25] L. Palma,et al. The importance of surgery in supratentorial ependymomas. Long-term survival in a series of 23 cases. , 2000, Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery.